BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiinflammatory activity of some 1-alkyl-4-phenylpyrido(2,3-d)pyrimidin-2(1H)-ones. 1974

G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue

UI MeSH Term Description Entries
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005620 Freund's Adjuvant An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria. Freund Adjuvant,Adjuvant, Freund,Adjuvant, Freund's,Freunds Adjuvant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
Synthesis of new 2-substituted pyrido[2,3-d]pyrimidin-4(1H)-ones and their antibacterial activity.
March 2009, European journal of medicinal chemistry,
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
An improved synthesis of pyrido[2,3-d]pyrimidin-4(1H)-ones and their antimicrobial activity.
May 2018, Organic & biomolecular chemistry,
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
Synthesis and anti-inflammatory properties of some pyrrolo(1H,3H)[3,4-d]pyrimidin-2-ones and pyrrolo(1H,6H)[3,4-d]pyrimidin-2-ones.
April 1979, Il Farmaco; edizione scientifica,
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
SYNTHESIS AND ACTIVITY OF 1-ALKYL-2-ARYL-2,3-DIHYDRO-4(1H)QUINAZOLINONES.
November 1963, Journal of pharmaceutical sciences,
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
Versatile solid-phase synthesis of trisubstituted 1H-pyrido[2,3-d]pyrimidin-4-ones and related heterocycles.
January 2005, Journal of combinatorial chemistry,
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
Synthesis and antihyperlipaemic activity of some 2-aminomethyl-3-aryl-5,6,7,8-tetrahydrobenzo(b)/5,6-dimethylthieno++ +(2,3- d) -pyrimidin-4-ones.
October 1996, Arzneimittel-Forschung,
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
Antitumor activity of novel pyrrolo[2,3-d]pyrimidin-4-ones.
July 2011, Drug and chemical toxicology,
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
Synthesis of 6-thiosubstituted 5-ethoxycarbonyl-1,3-diphenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-ones, 6-substituted 5-hydroxy-1,3-diphenyl-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-ones and their esters with local anesthetic, antiarrhythmic, antiinflammatory and analgesic activities.
January 1997, Farmaco (Societa chimica italiana : 1989),
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
Synthesis and antimicrobial activity of some thiazolinyl tetrahydrobenzo[b]thiophenes and thiazolinyl tetrahydrobenzothieno[2,3-d]pyrimidin-4-ones.
May 1992, Farmaco (Societa chimica italiana : 1989),
G E Hardtmann, and B Huegi, and G Koletar, and S Kroin, and H Ott, and J W Perrine, and J W Takesue
1-(4,6-Diethoxypyrimidin-2-yl)-2-thioxo-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-one.
November 2006, Acta crystallographica. Section C, Crystal structure communications,
Copied contents to your clipboard!